Meeting
2021 ASCO Annual Meeting
Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.
Authors
Joseph W. Kim
Yale Cancer Center, Yale School of Medicine, New Haven, CT
Joseph W. Kim , Marc R. Radke , Navid Hafez , Hatem Hussein Soliman , Siqing Fu , Shumei Kato , Primo "Lucky" N. Lara Jr., Ulka N. Vaishampayan , Albiruni Ryan Abdul Razak , Dana Backlund Cardin , Pamela N. Munster , Joseph Paul Eder , Yu Shyr , S. Percy Ivy , Patricia LoRusso , Elizabeth M. Swisher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Small Cell Lung Cancer
Clinical Trial Registration Number
NCT02498613
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 8563)
DOI
10.1200/JCO.2021.39.15_suppl.8563
Abstract #
8563
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
HRD signature and HRD genomic landscape of tumors from 896 patients with early-stage breast cancer (BC).
First Author: June Evelyn Jeon
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan